Company / Current Liabilities per Share
Harmony Biosciences Holdings, Inc. Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$4.41
FY2025
5-year range
$0.95 / $4.41
FY2021-FY2025
Trend
+43.1%
vs FY2024
Sector context
#42 of 210
Health Care
What the data says
Harmony Biosciences Holdings, Inc.'s current liabilities per share of $4.41 is higher than 80% of companies in the Health Care sector (FY2025). Current Liabilities per Share has increased for 4 consecutive years, from $0.95 in FY2021 to $4.41 in FY2025.
Based on SEC 10-K filings.
4.41 in FY2025 with a 5-year CAGR of -23.9%. Top quartile in the Health Care sector.
Increased from $2.75 to $4.41 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +48.7%
- 5-Year CAGR
- -23.9%
- 10-Year CAGR
- -
Sector benchmark
-72.0% below sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s current liabilities per share has grown for 4 consecutive years.
- In FY2025, current liabilities per share increased 43.1% year-over-year.
- Ranks #42 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.41 | +43.1% |
| FY2024 | $3.08 | +12.3% |
| FY2023 | $2.75 | +104.9% |
| FY2022 | $1.34 | +41.9% |
| FY2021 | $0.95 | -94.5% |
| FY2020 | $17.28 | +575.5% |
| FY2019 | $2.56 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026